BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 23596003)

  • 1. Mammary cancer bone metastasis follow-up using multimodal small-animal MR and PET imaging.
    Doré-Savard L; Barrière DA; Midavaine É; Bélanger D; Beaudet N; Tremblay L; Beaudoin JF; Turcotte EE; Lecomte R; Lepage M; Sarret P
    J Nucl Med; 2013 Jun; 54(6):944-52. PubMed ID: 23596003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with (18)F-FDG and bioluminescence imaging.
    Kang WJ; Song EH; Park JY; Park YJ; Cho A; Song HT
    Nucl Med Biol; 2015 Sep; 42(9):728-33. PubMed ID: 26068116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 18F-fluoride PET/MR and PET/CT in patients with foot pain of unclear cause.
    Rauscher I; Beer AJ; Schaeffeler C; Souvatzoglou M; Crönlein M; Kirchhoff C; Sandmann G; Fürst S; Kilger R; Herz M; Ziegler S; Schwaiger M; Eiber M
    J Nucl Med; 2015 Mar; 56(3):430-5. PubMed ID: 25678485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Study of Serial
    Peterson LM; O'Sullivan J; Wu QV; Novakova-Jiresova A; Jenkins I; Lee JH; Shields A; Montgomery S; Linden HM; Gralow J; Gadi VK; Muzi M; Kinahan P; Mankoff D; Specht JM
    J Nucl Med; 2018 Dec; 59(12):1823-1830. PubMed ID: 29748233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study.
    Nensa F; Tezgah E; Poeppel TD; Jensen CJ; Schelhorn J; Köhler J; Heusch P; Bruder O; Schlosser T; Nassenstein K
    J Nucl Med; 2015 Feb; 56(2):255-60. PubMed ID: 25552667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
    Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
    J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
    Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
    J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-18 fluoride uptake in primary breast cancer.
    Sarikaya I; Sharma P; Sarikaya A
    Ann Nucl Med; 2018 Dec; 32(10):678-686. PubMed ID: 30178199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
    Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
    Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study.
    Sharma P; Karunanithi S; Chakraborty PS; Kumar R; Seth A; Julka PK; Bal C; Kumar R
    Nucl Med Commun; 2014 Dec; 35(12):1247-53. PubMed ID: 25171438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.
    Simoncic U; Perlman S; Liu G; Jeraj R
    Nucl Med Commun; 2015 Dec; 36(12):1174-80. PubMed ID: 26378490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of MR-Based Attenuation Correction of a Newly Released Whole-Body Simultaneous PET/MR System.
    Liu G; Cao T; Hu L; Zheng J; Pang L; Hu P; Gu Y; Shi H
    Biomed Res Int; 2019; 2019():8213215. PubMed ID: 31886254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous PET/MR body imaging in rats: initial experiences with an integrated PET/MRI scanner.
    Tatsumi M; Yamamoto S; Imaizumi M; Watabe T; Kanai Y; Aoki M; Kato H; Shimosegawa E; Hatazawa J
    Ann Nucl Med; 2012 Jun; 26(5):444-9. PubMed ID: 22359223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
    Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
    J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
    Piccardo A; Puntoni M; Morbelli S; Massollo M; Bongioanni F; Paparo F; Altrinetti V; Gonella R; Gennari A; Iacozzi M; Sambuceti G; DeCensi A
    Nuklearmedizin; 2015; 54(4):163-72. PubMed ID: 26165806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
    Lin C; Bradshaw T; Perk T; Harmon S; Eickhoff J; Jallow N; Choyke PL; Dahut WL; Larson S; Humm JL; Perlman S; Apolo AB; Morris MJ; Liu G; Jeraj R
    J Nucl Med; 2016 Dec; 57(12):1872-1879. PubMed ID: 27445292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Dixon Sequence on Hybrid PET/MR Compared with Contrast-Enhanced PET/CT for PET-Positive Lesions.
    Jeong JH; Cho IH; Kong EJ; Chun KA
    Nucl Med Mol Imaging; 2014 Mar; 48(1):26-32. PubMed ID: 24900135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.